GentiBio
Michal Silverberg - Director
Adam Cotton - Observer
Immunology
Boston, USA
GentiBio engineers T cells to generate stable, scalable, IL2 and tissue targeted regulatory T cells better suited to address serious unmet medical needs for autoimmunity, alloimmunity, and autoinflammation.